Ex-Goldman Sachs Trader With Brain Cancer Has "The Answer"

Published: Dec 03, 2010

 Finance       

That is, Gordon Murray, a former bond trader at Goldman Sachs who later worked at Lehman Brothers and CSFB and who "decided to cease all treatment five months ago for his glioblastoma, a type of brain cancer," recently published The Investment Answer.

According to the Times, "the mere fact that Mr. Murray felt compelled to write it is itself a remarkable story of an almost willful ignorance of the futility of active money management — and how he finally stumbled upon a better way of investing. Mr. Murray now stands as one the highest-ranking Wall Street veterans to take back much of what he and his colleagues worked for during their careers."

Even more fascinating than a book about how Goldman Sachs and Credit Suisse and other Wall Street titans have it all wrong when it comes to investing is the answer to this question: If you had less than a year left to live, how would you spend your dying days?

I'm not sure what I'd do, but I think this guy is on to something. Happy Friday.

***

Related Content


Content Type

25 Best Investment Banks to Work for in 2022

Today, we're excited to release our 2022 Banking 25, a ranking of the best investment banking firms to work for in North America. The ranking is based on a survey of more than 3,600 banking professionals.

Content Type

Why Fintech Is Growing So Fast and How to Break Into This White-Hot Industry

Brian Hamilton is the founder and CEO of One, a fintech startup that provides digital banking services to the shrinking U.S. middle class.

Content Type

50 Best Accounting Firms for 2022

Today, we release our annual Accounting 50, a ranking of the best accounting firms to work for. The ranking is based on a survey of approximately 11,400 accounting professionals, who were asked to rate their firms in several workplace categories, including business outlook, compensation, culture, hours, training, overall satisfaction, and work/life balance.